首页> 美国卫生研究院文献>other >Phosphorylation of Ribosomal Protein S6 Kinase 1 at Thr421/Ser424 and Dephosphorylation at Thr389 Regulates SP600125-Induced Polyploidization of Megakaryocytic Cell Lines
【2h】

Phosphorylation of Ribosomal Protein S6 Kinase 1 at Thr421/Ser424 and Dephosphorylation at Thr389 Regulates SP600125-Induced Polyploidization of Megakaryocytic Cell Lines

机译:核糖体蛋白S6激酶1在Thr421 / Ser424上的磷酸化和Thr389上的去磷酸化调节SP600125诱导的巨核细胞系多倍体化。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Megakaryocytes (MKs) are one of the few cell types that become polyploid; however, the mechanisms by which these cells are designated to become polyploid are not fully understood. In this investigation, we successfully established two relatively synchronous polyploid cell models by inducing Dami and CMK cells with SP600125. We found that SP600125 induced the polyploidization of Dami and CMK cells, concomitant with the phosphorylation of ribosomal protein S6 kinase 1 (S6K1) at Thr421/Ser424 and dephosphorylation at Thr389. The polyploidization was partially blocked by H-89, a cAMP-dependent protein kinase (PKA) inhibitor, through direct binding to S6K1, leading to dephosphorylation at Thr421/Ser424 and phosphorylation at Thr389, independent of PKA. Overexpression of a rapamycin-resistant mutant of S6K1 further enhanced the inhibitory effect of on the SP600125-induced polyploidization of Dami and CMK cells. SP600125 also induced the polyploidization of Meg-01 cells, which are derived from a patient with chronic myelogenous leukemia, without causing a significant change in S6K1 phosphorylation. Additionally, SP600125 induced the polyploidization of HEL cells, which are derived from a patient with erythroleukemia, and phosphorylation at Thr389 of S6K1 was detected. However, the polyploidization of both Meg-01 cells and HEL cells as a result of SP600125 treatment was lower than that of SP600125-induced Dami and CMK cells, and it was not blocked by H-89 despite the increased phosphorylation of S6K1 at Thr389 in both cell lines in response to H-89. Given that the Dami and CMK cell lines were derived from patients with acute megakaryocytic leukemia (AMKL) and expressed high levels of platelet-specific antigens, our data suggested that SP600125-induced polyploidization is cell-type specific, that these cell lines were more differentiated, and that phosphorylation at Thr421/Ser424 and dephosphorylation at Thr389 of S6K1 may play an important role in the SP600125-induced polyploidization of these cell lines synergistically with other signaling pathways.
机译:巨核细胞(MKs)是少数成为多倍体的细胞类型之一。然而,这些细胞被指定为多倍体的机制尚不完全清楚。在这项研究中,我们通过用SP600125诱导Dami和CMK细胞成功建立了两个相对同步的多倍体细胞模型。我们发现SP600125诱导了Dami和CMK细胞的多倍化,并伴随着核糖体蛋白S6激酶1(S6K1)在Thr421 / Ser424的磷酸化和在Thr389的去磷酸化。多倍体化被c-AMP依赖性蛋白激酶(PKA)抑制剂H-89直接与S6K1结合而部分阻断,从而导致Thr421 / Ser424处的去磷酸化和Thr389处的磷酸化,独立于PKA。 S6K1的雷帕霉素抗性突变体的过表达进一步增强了SP600125诱导的Dami和CMK细胞多倍体化的抑制作用。 SP600125还诱导了Meg-01细胞的多倍化,该细胞来自患有慢性粒细胞性白血病的患者,而没有引起S6K1磷酸化的显着变化。此外,SP600125诱导了来自红白血病患者的HEL细胞的多倍化,并检测到S6K1在Thr389处的磷酸化。然而,SP600125处理导致Meg-01细胞和HEL细胞的多倍化均低于SP600125诱导的Dami和CMK细胞,尽管在Thr389处S6K1的磷酸化增加,但它并未被H-89阻断。两种细胞系均响应H-89。鉴于Dami和CMK细胞系均来自急性巨核细胞白血病(AMKL)患者并表达高水平的血小板特异性抗原,我们的数据表明SP600125诱导的多倍体化具有细胞类型特异性,这些细胞系的分化程度更高,并且S6K1的Thr421 / Ser424的磷酸化和Thr389的去磷酸化可能在SP600125诱导的这些细胞系多倍体化中与其他信号途径协同发挥重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号